Cardiac resynchronization therapy (CRT): Clinical trials, guidelines, and target populations

Heart Rhythm

Volumn 9, Issue 8 SUPPL., 2012, Pages S3-

  Linde, Cecilia ^a   Ellenbogen, Kenneth ^b   McAlister, Finlay A ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Arrhythmia; Biventricular pacing; Cardiac resynchronization therapy (CRT); Dyssynchrony; Heart failure; Narrow QRS; Nonresponder

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL PRACTICE; DEFIBRILLATOR; ELECTRIC CONDUCTIVITY; ENZYME ACTIVITY; EXERCISE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; SINUS RHYTHM; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84864281188     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.04.026     Document Type: Article

References (47)

1. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
2. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 Published erratum appears in N Engl J Med 2005;352:2146
3. S. Baldasseroni, C. Opasich, M. Gorini Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure Am Heart J 143 2002 398 405
4. S. Ghio, C. Constantin, C. Klersy Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration Eur Heart J 25 2004 571 578
5. D.A. Kass Cardiac resynchronization therapy J Cardiovasc Electrophysiol 16 2005 S35 S41
6. K. Chakir, S.K. Daya, R.S. Tunin Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization Circulation 117 2008 1369 1377
7. T. Aiba, G.G. Hesketh, A.S. Barth Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy Circulation 119 2009 1220 1230
8. S. Cazeau, C. Leclercq, T. Lavergne Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873 880
9. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
10. C. Leclercq, S. Walker, C. Linde Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation Eur Heart J 23 2002 1780 1787
11. A. Auricchio, C. Stellbrink, S. Sack Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay J Am Coll Cardiol 39 2002 2026 2033
12. J.B. Young, W.T. Abraham, A.L. Smith Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial JAMA 289 2003 2685 2694
13. S.L. Higgins, J.D. Hummel, I.K. Niazi Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias J Am Coll Cardiol 42 2003 1454 1459
14. W.T. Abraham, J.B. Young, A.R. León Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter- defibrillator, and mildly symptomatic chronic heart failure Circulation 111 2004 2684 2688
15. A. Auricchio, C. Stellbrink, C. Butter Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay J Am Coll Cardiol 42 2003 2109 2116
16. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
17. J.G.F. Cleland, J.-C. Daubert, E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
18. J.G.F. Cleland, J.-C. Daubert, E. Erdmann Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 16 2006 1928 1932
19. C. Linde, W.T. Abraham, M.R. Gold Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
20. A.J. Moss, W.J. Hall, D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
21. A.S. Tang, G.A. Wells, M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
22. S. Ghio, N. Freemantle, L. Scelsi Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial Eur Heart J 22 2009 480 488
23. A. Rossi, G. Rossi, M. Piacenti The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials Heart Vessels 23 2008 217 223
24. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 Eur Heart J 29 2008 2388 2442
25. K. Dickstein, P.E. Vardas, A. Auricchio 2010 Focused Update of ESC guidelines on device therapy in heart failure An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Europace 12 2010 1526 1536
26. C. Daubert, M.R. Gold, W.T. Abraham Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial J Am Coll Cardiol 54 2009 1837 1846
27. W. Zareba, H. Klein, I. Cygankiewicz Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Circulation 123 2011 1061 1072
28. S.A. Hunt, W.T. Abraham, M.H. Chin ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 112 2005 e154 e235
29. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults Circulation 119 2009 e391 e479
30. P.E. Vardas, A. Auricchio, J.J. Blanc Guidelines for cardiac pacing and cardiac resynchronization therapy Eur Heart J 28 2007 2256 2295
31. A. Arshad, A.J. Moss, E. Foster Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial J Am Coll Cardiol 57 2011 813 820
32. M. Packer Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure J Card Fail 7 2001 176 182
33. E.S. Chung, A.R. León, L. Tavazzi Results of the Predictors of Response to CRT (PROSPECT) Trial Circulation 117 2008 2608 2616
34. Abraham W. Presented at the Heart Rhythm Society 31st Annual Scientific Sessions, May 12-15, 2010m Denver, Colorado.
35. F.A. McAlister Applying evidence to patient care: from black and white to shades of grey (editorial) Ann Intern Med 138 2003 938 939
36. A.B. Curtis, C.W. Yancy, N.M. Albert Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF Am Heart J 158 2009 956 964
37. J.P. Piccini, A.F. Hernandez, D. Dai Use of cardiac resynchronization therapy in patients hospitalized with heart failure Circulation 118 2008 926 933
38. A.S. Fein, Y. Wang, J.P. Curtis Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry J Am Coll Cardiol 56 2010 766 773
39. D.J. van Veldhuisen, A.J. Maass, S.G. Priori Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008 Eur J Heart Fail 11 2009 1143 1151
40. F.A. McAlister, J.V. Tu, A. Newman How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts Eur Heart J 27 2006 323 329
41. G.C. Fonarow, N.M. Albert, A.B. Curtis Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596
42. N.S. Al-Majed, F.A. McAlister, J.A. Bakal, J.A. Ezekowitz Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure Ann Intern Med 154 2011 401 412
43. B.K. Fornwalt, W.W. Sprague, P. BeDell Agreement is poor among current criteria used to define response to cardiac resynchronization therapy Circulation 121 2010 1985 1991
44. A.F. Hernandez, G.C. Fonarow, B.G. Hamill Clinical effectiveness of implantable cardioverter-defibrillators among Medicare beneficiaries with heart failure Circ Heart Fail 3 2010 7 13
45. J. Ezekowitz, B.E.H. Rowe, D.M. Dryden Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction Ann Intern Med 147 2007 251 262
46. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
47. H.J. Shenkman, V. Pampati, A.K. Khandelwal Congestive heart failure and QRS duration: establishing prognosis study Chest 122 2002 528 534